Literature DB >> 34590321

Allergic contact dermatitis to clostridiopeptidase A with a nummular eczema-like spread.

Caterina Foti1, Gianluca Calianno1, Silvia Mazzotta1, Fabrizio Guarneri2, Paolo Romita1.   

Abstract

Entities:  

Keywords:  allergic contact dermatitis; case report; chloramphenicol; clostridiopeptidase A; collagenase I; leg ulcers; nummular eczema

Mesh:

Substances:

Year:  2021        PMID: 34590321      PMCID: PMC9297937          DOI: 10.1111/cod.13982

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.419


× No keyword cloud information.
Topical medications used for the treatment of venous leg ulcers are a well‐known cause of allergic contact dermatitis (ACD). Among these, topical drugs containing proteolytic enzymes (used for wound debridement) are rarely involved.2, 3 We herein report a case of severe ACD caused by clostridiopeptidase A, also known as collagenase I.

CASE REPORT

A nonatopic 64‐year‐old woman presented to our attention for the onset of a diffuse crusted eczematous dermatitis with nummular aspects (Figure 1). The patient reported that the eruption had started to appear about 2 weeks after the application of a topical ointment containing chloramphenicol 1% and clostridiopeptidase A 60 U.I. (Iruxol, Smith & Nephew GmbH, Hamburg, Germany) under occlusion with a zinc oxide bandage, prescribed by her physician to treat a venous ulcer on her left leg. The skin lesions appeared around the leg ulcer and then spread within 3 weeks to both lower limbs, the upper limbs, and trunk, with nummular eczema‐like aspects. Her physician already prescribed oral therapy with amoxicillin–clavulanate (875 + 125 mg twice daily) for 6 days; however, there was no improvement of the skin lesions. Use of the topical ointment was immediately discontinued, and topical application of mometasone furoate once daily resulted in healing of the eczematous lesions in 2 weeks. Four weeks after the resolution of the dermatitis, patch tests were performed with the SIDAPA (Società Italiana di Dermatologia Allergologica Professionale e Ambientale) baseline series (FIRMADiagent, Florence, Italy), a piece of the zinc oxide bandage, and the ointment used by the patient. Patch tests were applied on the back and left under occlusion for 2 days with Haye's Test Chambers (Haye's Service B.V., Alphen aan den Rijn, The Netherlands) on Soffix tape (Artsana, Grandate, Italy). Readings were performed on day (D) 2 and D4 according to guidelines, and showed a positive reaction to paraphenylenediamine (++, past relevance) and Iruxol ointment (++). Subsequently, patch tests were performed with chloramphenicol 5% pet. and Noruxol (containing clostridiopeptidase A, liquid paraffin, and white petrolatum; Smith & Nephew GmbH, Hamburg, Germany), liquid paraffin, and white petrolatum, yielding positivity only to Noruxol (++; Figure 1). Based on these findings, we diagnosed ACD to clostridiopeptidase A. Ten healthy individuals were patch tested with Iruxol and Noruxol with negative results.
FIGURE 1

(A) Eczematous lesions around the leg ulcer and (B) nummular eczema‐like spreading; (C) positive patch test to Noruxol “as is” on day 4

(A) Eczematous lesions around the leg ulcer and (B) nummular eczema‐like spreading; (C) positive patch test to Noruxol “as is” on day 4

DISCUSSION

ACD caused by topical medications is a well‐known, but probably underestimated and misdiagnosed complication. We herein reported a case of severe ACD caused by clostridiopeptidase A, a proteolytic enzyme widely used in wound and ulcer care. While chloramphenicol is a well‐known sensitizer, clostridiopeptidase A has rarely been reported as the culprit of ACD.2, 3 Nummular eczema is usually a manifestation of atopic dermatitis, but contact allergy has also been demonstrated to be associated with nummular eczema‐like aspects. To our knowledge, this is the first case of ACD to clostridiopeptidase A with a nummular eczema‐like spread. We speculate that the application of the medication under occlusion could have favoured contact sensitization and lymphatic and/or hematogenous dissemination, which are proposed mechanisms for ACD spreading. Beyond the peculiar clinical manifestations, our case highlights that contact sensitization to topical medications containing clostridiopeptidase A, although rare, should be always borne in mind by physicians.

CONFLICTS OF INTEREST

All the authors have no conflict of interest to declare.

AUTHOR CONTRIBUTIONS

Caterina Foti: Conceptualization (equal); data curation (equal); supervision (equal); writing – review and editing (equal). Gianluca Calianno: Conceptualization (equal); data curation (equal). Silvia Mazzotta: Data curation (equal); formal analysis (equal). Fabrizio Guarneri: Data curation (equal); formal analysis (equal); supervision (equal). Paolo Romita: Conceptualization (equal); data curation (equal); formal analysis (equal); supervision (equal); validation (equal); writing – review and editing (equal).
  9 in total

1.  Extensive allergic contact dermatitis from a topical enzymatic preparation (Noruxol).

Authors:  P Lisi; L Brunelli
Journal:  Contact Dermatitis       Date:  2001-09       Impact factor: 6.600

2.  Italian Guidelines in Patch Testing - adapted from the European Society of Contact Dermatitis (ESCD).

Authors:  Luca Stingeni; Leonardo Bianchi; Katharina Hansel; Monica Corazza; Rosella Gallo; Fabrizio Guarneri; Cataldo Patruno; Luigi Rigano; Paolo Romita; Paolo D Pigatto; Piergiacomo Calzavara-Pinton
Journal:  G Ital Dermatol Venereol       Date:  2019-02-04       Impact factor: 2.011

3.  Allergic contact dermatitis caused by chloramphenicol with prurigo nodularis-like spreading.

Authors:  Paolo Romita; Luca Stingeni; Katharina Hansel; Grazia Ettorre; Anna Bosco; Francesca Ambrogio; Caterina Foti
Journal:  Contact Dermatitis       Date:  2019-01-10       Impact factor: 6.600

4.  Nummular eczema and contact allergy: a retrospective study.

Authors:  Domenico Bonamonte; Caterina Foti; Michelangelo Vestita; Luigi Davide Ranieri; Gianni Angelini
Journal:  Dermatitis       Date:  2012 Jul-Aug       Impact factor: 4.845

5.  [Frequency of contact sensitization to modern dressings used to treat chronic leg ulcer].

Authors:  E Garval; J Plee; C Lesage; A Grange-Prunier; P Bernard; G Perceau
Journal:  Ann Dermatol Venereol       Date:  2018-04-17       Impact factor: 0.777

6.  Contact dermatitis with clostridiopeptidase A contained in Noruxol ointment.

Authors:  Caterina Foti; Anna Conserva; Claudia Casulli; Valentina Scrimieri; Maria Luisa Pepe; Domenico Quaranta
Journal:  Contact Dermatitis       Date:  2007-06       Impact factor: 6.600

Review 7.  Allergic contact dermatitis: clinical aspects.

Authors:  Jean-Marie Lachapelle
Journal:  Rev Environ Health       Date:  2014       Impact factor: 3.458

8.  Contact Sensitization in Patients with Chronic Leg Ulcers: Results of a 5-Year Retrospective Analysis.

Authors:  Tadas Raudonis; Rasa Aurelija Vankeviciute; Andre Lideikaite; Anna Greta Grigaityte; Jurate Grigaitiene
Journal:  Adv Skin Wound Care       Date:  2019-12       Impact factor: 2.347

9.  Allergic contact dermatitis to clostridiopeptidase A with a nummular eczema-like spread.

Authors:  Caterina Foti; Gianluca Calianno; Silvia Mazzotta; Fabrizio Guarneri; Paolo Romita
Journal:  Contact Dermatitis       Date:  2021-10-18       Impact factor: 6.419

  9 in total
  1 in total

1.  Allergic contact dermatitis to clostridiopeptidase A with a nummular eczema-like spread.

Authors:  Caterina Foti; Gianluca Calianno; Silvia Mazzotta; Fabrizio Guarneri; Paolo Romita
Journal:  Contact Dermatitis       Date:  2021-10-18       Impact factor: 6.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.